Adagio Medical Holdings, Inc. (ADGM) Reports Q4 Earnings
ADGM|EPS -$0.21|Rev $0|Net Loss $3.3M Adagio Medical Holdings, Inc. reported a narrower quarterly loss for the fourth quarter of 2025, though the developmental stage cardiac device maker recorded zero revenue as it continues work on its ablation technology platform. The company posted a diluted net loss per share of -$0.21, compared to -$3.62 a year […]
Adagio Medical Holdings, Inc. (ADGM) Reports Q4 Earnings Read More »









